Introduction {#s1}
============

Maintaining the structural and mechanical integrity of tissues in the musculoskeletal system, and other connective tissues, is fundamental to sustain tissue homeostasis and healthy function, requiring protein synthesis and degradation to repair and/or replace damaged tissue before damage accumulates and leads to injury ([@bib17]). However, while the composition and structure of connective tissues is well defined ([@bib44]), relatively little is known regarding proteome dynamics in connective tissues, particularly at the level of the individual constituent proteins.

Connective tissues consist of fibrous proteins (predominantly collagen) embedded in a glycoprotein-rich matrix ([@bib44]), and variation in the organisation of both phases give rise to tissues with distinct structural and mechanical properties ([@bib10]). Research in a variety of tissues including skin, tendon and cartilage indicates a relatively long half-life of collagens, with more rapid turnover of glycoproteins and other non-collagenous proteins ([@bib54]; [@bib32]; [@bib46]; [@bib47]; [@bib61]). Indeed, several studies have reported negligible turnover of collagen, the major component of tendon and other connective tissues, within an individual's lifetime ([@bib54]; [@bib14]; [@bib15]). However other studies have measured relatively rapid collagen synthesis in tendon, both at basal levels and in response to exercise ([@bib36]), and also identified soluble collagen with a much shorter half-life compared to the majority of collagen in human articular cartilage ([@bib16]); the location(s) of these more labile proteins remain to be identified. When taken together, these contradictory findings indicate that proteome dynamics in connective tissues is complex, and that the glycoprotein-rich phase may be replenished more rapidly than the collagen-rich phase. However, the turnover rate of individual proteins within the different phases of the extracellular matrix (ECM), and the potential contribution of differential regulation of protein turnover to maintenance of tissue homeostasis remain undefined.

Tendon provides an ideal model in which to separately interrogate protein turnover in these ECM phases, as it consists of highly aligned, collagen-rich fascicular matrix (FM), interspersed by a less dense glycoprotein-rich phase, termed the interfascicular matrix (IFM, also referred to as the endotenon) ([@bib21]). While the FM is predominantly composed of type I collagen, glycoproteins are also present in this region at low abundance ([@bib59]). Similarly, the IFM contains small amounts of a variety of collagens ([@bib49]; [@bib59]). Due to the highly aligned structure of tendon tissue, it is possible to separate FM and IFM for individual analysis using laser capture microdissection ([@bib59]; [@bib66]). Indeed, these, and other studies, have shown greater expression of markers of ECM degradation, as well as increased neo-peptide levels, a proxy measure of protein turnover, within the IFM ([@bib50]; [@bib56]; [@bib59]), suggesting this region is more prone to microdamage, likely due to the high shear environment that occurs due to interfascicular sliding ([@bib55]; [@bib57]). Taken together, these findings suggest that there is greater turnover of ECM proteins localised to the IFM than within the FM to repair local microdamage and maintain tendon homeostasis.

Due to a lack of available methodology, it has not been possible until recently to study differential rate of turnover at the individual protein level. However, novel bioinformatics software developments, in combination with in vivo isotope labelling, and mass spectrometry technologies, now provide the capacity to determine the turnover rates of individual proteins within a sample ([@bib25]; [@bib29]; [@bib30]). The aim of this study is therefore to apply this technique to tendon, firstly to establish the proteome-wide turnover rate of tendon, and secondly to combine this approach with laser capture microdissection to test the hypothesis that the proteome of the IFM is more dynamic than in the FM, with faster turnover of individual proteins. More rapid remodelling of the IFM would provide a mechanism by which shear-induced microdamage to this region could be repaired, preventing damage accumulation and subsequent injury.

Results {#s2}
=======

^2^H enrichment in serum water {#s2-1}
------------------------------

In rats labelled with deuterium over a period of 127 days ([Figure 1a](#fig1){ref-type="fig"}), ^2^H enrichment of serum occurred rapidly and in a similar manner to that reported previously in rodents ([@bib25]), reaching a plateau of 5.6% by day 4, and remained constant throughout the study ([Figure 1b](#fig1){ref-type="fig"}). The enrichment curve, which was empirically derived from the GC-MS measurements at the sampled time points, defines two parameters: deuterium enrichment rate (*k~p~*) = 0.7913 and plateau (*p*~ss~) = 0.0558; these values were used for subsequent kinetic curve fitting to calculate peptide turnover rate constants (*k*).

![Metabolic labelling of rats using deuterium.\
(**A**) Schematic showing ^2^H~2~O labelling of rats and details of sample collection, and interfascicular matrix isolation by laser capture microdissection (scale bar = 100 µm). (**B**) ^2^H enrichment in serum occurred rapidly, reaching a plateau of 5.6% by day 4 and remained constant throughout the study. Data are shown as mean ± SD and raw data provided in [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}. (**C**) Example extracted ion chromatograms from tendon samples demonstrating increased abundance of higher mass isotopomer peaks over the course of the study (M~1~ -- M~5~). (**D**) Example curve showing the relative abundance of the unlabelled monoisotopic peak (M~0~) for the cartilage oligomeric matrix protein (COMP) peptide QMEQTYWQANPFR, calculated by ProTurn software and plotted as a function of time.\
Figure 1---source data 1.Enrichment of serum water as measured by GC-MS.](elife-55262-fig1){#fig1}

Protein identification {#s2-2}
----------------------

190 proteins with ≥2 unique peptides were identified in whole tendon digests and protein interactions are shown in [Figure 2](#fig2){ref-type="fig"}. Of these proteins, 72 were classified as ECM or ECM-related proteins by MatrisomeDB ([@bib18]). In samples collected by laser capture microdissection of tendon cryosections, 266 proteins with ≥2 unique peptides were identified in the IFM, 79 of which were ECM or ECM-related proteins ([Figure 3](#fig3){ref-type="fig"}). In the FM, 116 proteins were identified, of which 71 were ECM or ECM-related proteins ([Figure 4](#fig4){ref-type="fig"}). Protein interactions for each tendon component demonstrate a complex and highly interconnected proteome in tendon and its ECM phases.

![Protein-protein interaction map of proteins identified in whole tendon.\
Unconnected nodes were removed to provide clarity of the interactome. The total cluster was built with STRING ([@bib52]) allowing for experimentally verified and predicted protein-protein interactions at high confidence levels (0.700). Line thickness indicates the strength of supporting data. Source data are provided in [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}.\
Figure 2---source data 1.Proteins identified in whole tendon samples used to create protein-protein interaction maps.](elife-55262-fig2){#fig2}

![Protein-protein interaction map of proteins identified in the interfascicular matrix.\
Unconnected nodes were removed to provide clarity of the interactome. The total cluster was built with STRING ([@bib52]) allowing for experimentally verified and predicted protein-protein interactions at high confidence levels (0.700). Line thickness indicates the strength of supporting data. Source data are provided in [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}.\
Figure 3---source data 1.Proteins identified in the interfascicular matrix used to create protein-protein interaction maps.](elife-55262-fig3){#fig3}

![Protein-protein interaction map of proteins identified in the fascicular matrix.\
Unconnected nodes were removed to provide clarity of the interactome. The total cluster was built with STRING ([@bib52]) allowing for experimentally verified and predicted protein-protein interactions at high confidence levels (0.700). Line thickness indicates the strength of supporting data. Source data are provided in [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}.\
Figure 4---source data 1.Proteins identified in the fascicular matrix used to create protein-protein interaction maps.](elife-55262-fig4){#fig4}

Protein turnover in whole tendon {#s2-3}
--------------------------------

Peptide turnover rates were calculated using ProTurn (v2.1.05; available at <http://proturn.heartproteome.org>; [@bib29]; [@bib30]; [@bib31]; [@bib62]), which automatically calculates turnover rate constants for all peptides that pass the selection criteria using non-steady state curve fitting ([Figure 1](#fig1){ref-type="fig"}). To assure data quality, we used a stringent cut-off, passing only peptides that are identified at 1% false discovery rate (FDR) and quantified at four or more time points. In total, 455 peptides, relating to 41 proteins, passed the ProTurn selection criteria and were used to calculate protein half-life in whole tendon samples.

The relative abundance of the unlabelled monoisotopic peak (M~0~), plotted as a function of time for selected decorin and collagen peptides are shown in [Figure 5a&b](#fig5){ref-type="fig"}. Non-steady state curve fitting was performed by ProTurn to calculate turnover rate constants (*k*) for each peptide, and resultant fractional synthesis curves in [Figure 5c&d](#fig5){ref-type="fig"} demonstrate much faster turnover of decorin peptides compared to collagen types 1 and 3. *k* values for all peptides identified, and corresponding protein half-lives are shown in [Figure 6](#fig6){ref-type="fig"}. As expected, the smallest *k* values related to collagenous proteins, with corresponding half-lives of 330 to 1086 days. By contrast, the protein identified with the fastest turnover was the glycoprotein clusterin, with a half-life of 1.4 days. The half-life of proteoglycans ranged from 21 days for decorin to 72 days for lumican. With the exception of collagens, which all exhibited low turnover rates, there was no clear relationship between protein class and rate of turnover ([Figure 6c](#fig6){ref-type="fig"}).

![Calculation of protein turnover rate from mass isotopomer distribution over time.\
Relative abundance of M~0~ in selected decorin (**A**) and collagen type 1, alpha one chain (**B**) peptides, and resulting *k* values calculated by non-steady state curve fitting using ProTurn software. Fractional synthesis rates (FSR), calculated from peptide *k* values, demonstrate more rapid turnover of decorin (**C**) compared to collagen type 1, alpha one chain (**D**). Source data, generated by ProTurn are available in [Source data 1](#sdata1){ref-type="supplementary-material"}.](elife-55262-fig5){#fig5}

![Peptide turnover rate constants and corresponding protein half-lives in whole tendon.\
(**A**) The peptide rate constants (k) for individual proteins are plotted in descending order on a logarithmic scale, with the median value represented by a red line. (**B**) The median *k* values for each protein were used to calculate protein half-life, assuming a first order reaction. (**C**) Protein turnover rates plotted against MatrisomeDB and PANTHER categories, with the median value represented by a red line. Due to space constraints, gene, rather than protein, names are displayed in parts *A* and *B.* Source data, generated by ProTurn are available in [Source data 1](#sdata1){ref-type="supplementary-material"}.](elife-55262-fig6){#fig6}

Protein turnover in tendon compartments {#s2-4}
---------------------------------------

246 peptides, relating to 20 proteins, and 121 peptides, relating to 12 proteins, passed the ProTurn selection criteria in the FM and IFM respectively. 55 peptides were present both in the IFM and FM, and *k* values were significantly greater for these peptides in the IFM compared to the FM (median: 0.018 vs. 0.010; p\<0.0001), demonstrating an overall faster rate of protein turnover in the IFM. 39 peptides relating to collagen type I were identified in both the IFM and FM, with significantly greater *k* values in the IFM (p\<0.0001; [Figure 7a](#fig7){ref-type="fig"}). The turnover rate constants and resultant half-lives for proteins identified in each tendon phase are shown in [Figure 4b](#fig4){ref-type="fig"}. Turnover rate constants for Col1a1 and Col1a2 were significantly higher in the IFM compared to the FM, but there were no significant differences in rate constants for Col3a1 between tendon phases.

![Peptide turnover rate constants and corresponding protein half-lives in tendon phases.\
(**A**) Rate constants (k) for collagen type I peptides identified in both tendon phases were significantly greater in the IFM compared to the FM (n = 39). (B) Median peptide decay curves for Col1a1 and Col1a2 in the FM (▲; solid line) and IFM (●; dashed line), showing goodness of fit (r^2^) and standard error (S.E.). (**C**) Turnover rate constants (k) and corresponding half-lives for proteins identified in each phase. \*\*\* indicates p\<0.0001. Source data, generated by ProTurn are available in [Figure 7---source data 1](#fig7sdata1){ref-type="supplementary-material"} for the FM and [Figure 7---source data 2](#fig7sdata2){ref-type="supplementary-material"} for the IFM.\
Figure 7---source data 1.ProTurn output for FM.hl tab contains protein half-life information organized by peptide sequence and hl-data tab contains isotopomer relative abundance at each time point.\
Figure 7---source data 2.ProTurn output for IFM.hl tab contains protein half-life information organized by peptide sequence and hl-data tab contains isotopomer relative abundance at each time point.](elife-55262-fig7){#fig7}

Due to ProTurn software identifying a low number of proteins in laser captured samples, particularly in the IFM, turnover rate constants in tendon phases were calculated manually for a number of proteins of interest ([Figure 8](#fig8){ref-type="fig"}). Rate constants of turnover of decorin peptides were significantly higher in the IFM compared to the FM ([Figure 8](#fig8){ref-type="fig"}). It was not possible to assess differences in turnover of other proteins due to a low number of peptides identified at sufficient time points to allow accurate curve fitting ([Figure 8c](#fig8){ref-type="fig"}).

![Manual calculation of turnover rate of selected proteins.\
(**A**) Relative abundance of M~0~ as a function of time, and resultant non-linear curve fitting for peptides corresponding to decorin identified in the FM (▲; solid line) and IFM (●; dashed line). (**B**) Resultant k values for decorin peptides were significantly greater in the IFM than in the FM (p=0.042). (**C**) Manually calculated turnover rate constants (k) and corresponding half-lives for tendon proteins of interest. Source data are available in [Figure 8---source data 1](#fig8sdata1){ref-type="supplementary-material"}.\
Figure 8---source data 1.GraphPad Prism output showing the manually calculated relative abundance of M~0~ at different time points for decorin, fibromodulin, biglycan and Col3a1 peptides, and resultant K values.](elife-55262-fig8){#fig8}

Discussion {#s3}
==========

This is the first study to investigate the proteome-wide turnover rate of tendon and its constituent ECM phases, demonstrating complex proteome dynamics in whole tendon. Protein turnover rate in tendon varied almost 1000-fold, with half-lives ranging from 1.5 days to over 1000 days. The results also support our hypothesis, demonstrating significantly faster turnover of proteins in the glycoprotein-rich IFM compared to the collagen-rich FM, both overall and when directly comparing individual proteins.

In agreement with previous studies ([@bib59]), the IFM had a more complex proteome than the FM, with a greater number of proteins identified in this region. Indeed, more proteins were identified within the IFM than in whole tendon samples; this is likely due to the predominance of collagen in whole tendon samples which precludes detection of proteins present at lower abundance in these samples. As many of the proteins present in the IFM were identified in less than four samples, it was not possible to perform curve fitting to calculate the turnover rate for these proteins. Due to the small size of the rat Achilles tendon, it was not possible to laser-capture a larger volume of IFM, and pooling samples from each time point for LC-MS/MS analysis did not result in a greater number of protein hits than when each sample was analysed separately. In addition, it was necessary to calculate turnover rates of some proteins manually as automated identification of isotopomer peaks was unsuccessful, particularly in IFM samples. While turnover rates calculated manually cannot be compared directly to those calculated automatically by ProTurn, due to differences in curve fitting, it is possible to compare turnover rates of IFM and FM proteins, where both are calculated manually. Additionally, only tendons from female rats were used, such that any differences in turnover rate between sexes could not assessed. While no previous studies have directly compared tendon turnover rates in males and females, it has been demonstrated that there are very small differences in the transcriptome and proteome of Achilles tendons from male and female mice ([@bib42]). Despite these limitations, results reveal a diverse rate of protein turnover in both the FM and IFM, with values for individual proteins similar to those observed when the tendon matrix was analysed as a whole.

Collagenous proteins had the slowest turnover of all tendon matrix proteins identified, in the whole tendon, and in the FM and IFM, with a half-life from approximately 1.5 years in the IFM to 3 years in the FM for type I collagen. Collagen type III appeared to have a somewhat faster turnover rate than type I in both the FM and IFM, with no significant difference between phases. The IFM is known to be enriched in collagen type III, whereas the majority of collagen type I localises to the FM ([@bib49]; [@bib59]). While the collagen turnover rates measured are relatively slow, they contrast with previous studies which have reported that collagen is essentially inert in the adult rat patellar tendon ([@bib5]) and in tendons from larger animals ([@bib14]; [@bib54]), as well as in cartilage and intervertebral disc ([@bib15]; [@bib47]). However, these previous studies have either analysed tissues as a whole, or separated the tissue into collagenous and non-collagenous fractions, rather than calculating turnover of individual proteins, such that they lack the specificity achieved by using deuterium labelling combined with mass spectrometry analysis. Other studies that have measured collagen synthesis in human tendon using stable isotope labelling and performing tendon biopsies, report contradictory findings, calculating a FSR of 0.04--0.06% hour^−1^, which equates to a half-life ranging from 48 to 64 days ([@bib36]; [@bib4]; [@bib48]). However, these were very short term studies, and it is unlikely that all newly synthesised protein would be incorporated into the matrix, such that FSR is over-estimated ([@bib14]). The results we present here help to explain these apparent contradictory findings, suggesting that the pool of more labile collagen identified previously in human tendon and cartilage ([@bib36]; [@bib16]) may be located in the glycoprotein-rich ECM phase rather than with the bulk of the fascicular collagen.

Another factor that is likely to influence tendon remodelling is the regulation of post-translational modifications. ECM proteins, particularly collagens, undergo a wide range of post-translational modifications during synthesis and assembly which occur both intra- and extra-cellularly, either through regulated pathways or spontaneously ([@bib65]; [@bib3]). Post-translational modifications are essential for determining protein structure and function, and are also likely to influence susceptibility to degradation by limiting enzyme access to cleavage sites ([@bib19]). Indeed, a previous study has shown that, with ageing, partially degraded collagen accumulates within the equine superficial digital flexor tendon ([@bib54]). This is accompanied by increased advanced glycation end products which may render the ECM more resistant to degradation and subsequent remodelling, reducing the ability to repair damage within the tendon ([@bib54]). However, the effects of alterations in post-translations modifications on rates of protein turnover remain to be determined.

In addition, it is likely that overall protein turnover rate is more rapid in small compared to large animals. While few studies have directly compared protein turnover kinetics between species, a recent study of protein turnover in dermal fibroblasts from different rodent species demonstrated a negative correlation between median *k* values and lifespan ([@bib51]). In support of this, the half-life of serum albumin is approximately 10 fold greater in the human compared to the rat ([@bib6]; [@bib20]). Taken together, it can be presumed that turnover of tendon ECM proteins is also likely slower in larger animals than those we report here for the rat, but the relative differences observed between individual proteins and ECM phases are likely to persist in humans and other large animals.

It is also important to recognise that specific proteins that are not core components of the tendon ECM will not be metabolised within the tendon, but instead will be synthesised elsewhere and transported to the tendon via the circulation. Specifically, serum albumin and serotransferrin are predominantly synthesised and secreted by the liver ([@bib53]), whereas haemoglobin is synthesised in the bone marrow and its turnover provides a measure of erythrocyte lifespan ([@bib26]). In addition, anionic trypsin-1, which had a particularly long half-life of nearly 2000 days in the FM, is synthesised in the pancreas. The long half-life measured for this protein is rather surprising, as generally enzymes have a much shorter half-life than ECM proteins ([@bib28]) Proteases have a role in tissue repair ([@bib45]); it is possible that there is a pool of trypsin within tendon that remains inactive until required for repair, which would explain the long half-life measured.

The measured rate constants of protein turnover will also be dependent on the protein extraction methods used. We chose GuHCl extraction for whole tendon as this has previously been shown to result in best proteome coverage for tendon ([@bib2]). It was not possible to use the same extraction method for laser-captured samples due to the small amount of starting material, therefore we used a method previously optimised for this sample type ([@bib59]). Despite differences in extraction techniques used, protein half-lives were similar in the whole tendon and the fascicular matrix, suggesting minimal effects from using different extraction techniques. Indeed, previous studies, in which the rat Achilles was acid-solubilised post deuterium labelling and FSR measured by GC-MS, reported a FSR of 0.66 % day^−1^ ([@bib22]) which equates to a half-life of 105 days, supporting the results we present here, in which average protein half-life in whole tendon is 131 days.

As well as providing the first data on individual protein turnover rates in tendon, this work builds on our understanding of the role of the IFM in tendon function. Previous work has shown that the IFM has specialised composition and function, facilitating sliding between tendon fascicles to provide extensibility to the tendon ([@bib55]; [@bib57]; [@bib59]; [@bib60]; [@bib58]). Cyclic sliding and recoil increases the risk of microdamage to this region ([@bib50]), and therefore greater turnover of IFM proteins may be a protective mechanism to repair this damage. We have previously demonstrated that elastin and lubricin are localised to the IFM and likely contribute to its mechanical function ([@bib12]; [@bib58]). However, these proteins are difficult to identify using LC-MS/MS ([@bib59]) so we were unable to assess their rate of turnover.

We extend previous observations in tendon and other musculoskeletal tissues ([@bib54]; [@bib46]; [@bib32]; [@bib16]), measuring considerably faster turnover of proteoglycans compared to collagens in tendons, FM and IFM. Interestingly, there were variations in rates of small leucine-rich proteoglycan turnover between tendon phases. Significantly faster turnover of decorin was observed in the IFM compared to the FM, whereas the results suggest that faster fibromodulin turnover may occur within the FM. Indeed, previous studies have shown differential abundance of specific proteoglycans in the IFM and FM, with enrichment of fibromodulin in the FM, but no significant differences in amounts of decorin, biglycan or lumican between tendon phases, as determined by proteomic analysis and immunohistochemistry ([@bib59]; [@bib58]). While use of mouse knock out models have established the roles of a variety of proteins during tendon development, with collagen type V, decorin, biglycan, fibromodulin, lumican and thrombospondins all serving roles in modulating collagen fibrillogenesis ([@bib9]; [@bib11]), the contributions of these proteins to the function of mature tendon are less well characterised. Recent work using decorin and biglycan inducible knock-out mice demonstrated alterations in collagen fibril diameter and decreased tendon mechanical properties in the adult, indicating an important role for these proteoglycans in FM and subsequently, tendon homeostasis ([@bib39]). It is likely that proteoglycans also contribute to homeostasis within the IFM, but the roles of specific proteins in the IFM during development and in the adult remain to be defined.

Our results show that proteome dynamics in tendon is highly complex, with differences in protein-selective turnover rates observed in distinct IFM and FM ECM phases. Regulation of protein turnover is multifactorial, involving pathways controlling protein synthesis, folding, transport, assembly, disassembly, and degradation ([@bib38]). Recent studies have identified the important role of transforming growth factor-β (TGF-β) in regulating ECM remodelling in tendon and other tissues ([@bib13]; [@bib41]). Indeed, it has been shown that TGF-β localises to the IFM in developing and adult tendon ([@bib27]; [@bib40]), which is consistent with the notion that increased TGF-β signalling could have a role in this faster protein turnover identified in the IFM.

Conclusions {#s3-1}
-----------

This is the first study to determine the turnover rate of individual proteins in different connective tissue phases, demonstrating complex proteome dynamics in tendon, with an overall faster turnover of proteins in the glycoprotein-rich IFM phase. Greater capacity for turnover of this phase of the tendon matrix may be indicative of a mechanism that reduces the accumulation of damage caused by the high shear environment within this region, although this remains to be directly determined. The techniques used here provide a powerful approach to interrogate alterations in connective tissue protein turnover with ageing and/or disease which are likely to influence injury risk.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                             Designation                                     Source or reference                                             Identifiers                                                                                           Additional\
  (species) or resource                                                                                                                                                                                                                                                           information
  --------------------------------------------------------- ----------------------------------------------- --------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- -------------
  Strain, strain background (*Rattus Norvegicus, Female*)   Wistar                                          Charles River                                                   RRID:[RGD_13508588](https://scicrunch.org/resolver/RGD_13508588)                                      Female

  Commercial assay or kit                                   Pierce protein assay                            ThermoFisher                                                    22660                                                                                                 

  Chemical compound, drug                                   \[^2^H\]~2~O                                    CK isotopes LtD                                                 DLM-2259                                                                                              

  Chemical compound, drug                                   Acetonitrile with 0.1% formic acid LCMS grade   Fisher Scientific                                               10723857                                                                                              

  Chemical compound, drug                                   Ammonium bicarbonate                            Sigma                                                           09830                                                                                                 

  Chemical compound, drug                                   Chondroitinase ABC                              Sigma                                                           C3667                                                                                                 

  Chemical compound, drug                                   Dithiothreitol                                  Melford laboratories                                            MB1015                                                                                                

  Chemical compound, drug                                   Formic acid (0.1% v/v) LCMS grade               Fisher Scientific                                               10188164                                                                                              

  Chemical compound, drug                                   Guanidine hydrocholoride                        Sigma                                                           G3272                                                                                                 

  Chemical compound, drug                                   Iodoacetamide                                   Sigma Aldrich                                                   I1149                                                                                                 

  Chemical compound, drug                                   RapiGest SF                                     Waters                                                          186001861                                                                                             

  Chemical compound, drug                                   Trifluoroacetic acid Optima                     Fisher Scientific                                               10723857                                                                                              

  Chemical compound, drug                                   Trifluoroacetic acid (0.1% v/v) LCMS grade      Fisher Scientific                                               10516625                                                                                              

  Chemical compound, drug                                   Trypsin Gold MS grade                           Promega                                                         V5280                                                                                                 

  Software, algorithm                                       Peaks Studio v8.5                               Bioinformatics Solutions                                        [www.bioinfor.com/peaks-studio](http://www.bioinfor.com/peaks-studio)                                 

  Software, algorithm                                       STRING v11.0                                    PMID:[30476243](https://www.ncbi.nlm.nih.gov/pubmed/30476243)   [string-db.org](https://string-db.org/cgi/input.pl)                                                   

  Software, algorithm                                       MatrisomeDB                                     PMID:[21937732](https://www.ncbi.nlm.nih.gov/pubmed/21937732)   [matrisomeproject.mit.edu](http://matrisomeproject.mit.edu/)                                          

  Software, algorithm                                       PANTHER                                         PMID:[23868073](https://www.ncbi.nlm.nih.gov/pubmed/23868073)   [www.pantherdb.org](http://www.pantherdb.org)                                                         

  Software, algorithm                                       ProLuCID                                        PMID:[26171723](https://www.ncbi.nlm.nih.gov/pubmed/26171723)   [fields.scripps.edu/yates/wp/?page_id = 821](http://fields.scripps.edu/yates/wp/?page_id%20=%20821)   

  Software, algorithm                                       ProteoWizard v3                                 PMID:[28188540](https://www.ncbi.nlm.nih.gov/pubmed/28188540)   [proteowizard.sourceforge.net/index.html](http://proteowizard.sourceforge.net/index.html)             

  Software, algorithm                                       ProTurn                                         PMID:[24614109](https://www.ncbi.nlm.nih.gov/pubmed/24614109)   [proturn.heartproteome.org](http://proturn.heartproteome.org/)                                        

  Software, algorithm                                       Prism v8.2                                      GraphPad                                                        [www.graphpad.com](http://www.graphpad.com)                                                           

  Other                                                     Filter units, Vivacon 500 10000 MWCO            Sartorius                                                       VN01H02                                                                                               
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Animals {#s4-1}
-------

\- Female Wistar rats (n = 24, 12 week old, weight: 270 ± 18 g, range: 228--299 g, specific pathogen free, Charles River Company, UK) were randomly housed in polypropylene cages in groups of 3, subjected to 12 hr light/dark cycle with room temperature at 21 ± 2°C and fed ad libitum with a maintenance diet (Special Diet Services, Witham UK). All procedures complied with the Animals (Scientific Procedures) Act 1986, were approved by the local ethics committee at the Royal Veterinary College, were performed under project licence PB78F43EE and are reported according to the ARRIVE guidelines ([@bib24]).

In vivo isotope labelling {#s4-2}
-------------------------

 All rats, with the exception of the controls (n = 3) received two intraperitoneal injections of 99% \[^2^H\]~2~O (10 ml/kg; CK isotopes Ltd) spaced 4 hr apart, and were then allowed free access to 8% \[^2^H\]~2~O (v/v) in drinking water for the duration of the study to maintain steady-state labelling ([@bib25]). All rats were acclimatized for 1 week prior to commencement of the study, and monitored daily and weighed weekly throughout the study; no adverse effects were observed. Rats in the control group were sacrificed on day 0. Rats in the isotope labelled groups were sacrificed on day 1, 3, 6, 15, 31, 63 and 127 (n = 3 per time point). Rats were culled at the same time of day (10 am) at each time point, to minimise any effect from diurnal variations. Blood was collected from each rat immediately post-mortem, and allowed to clot at room temperature. Blood samples were centrifuged at 1500 g for 10 min, and serum collected and stored at −20°C prior to analysis. Both Achilles tendons were harvested within 2 hr of death. The left Achilles was snap frozen in n-hexane cooled on dry ice for proteomic analysis of the whole tissue, and the right Achilles was embedded in optimal cutting temperature compound and snap frozen in n-hexane cooled on dry ice for isolation of fascicular and interfascicular matrices ([Figure 1a](#fig1){ref-type="fig"}).

GC-MS analysis of serum water {#s4-3}
-----------------------------

^2^H labelling in serum was measured via gas chromatography-mass spectrometry (GC-MS) after exchange with acetone and extraction with chloroform as described previously ([@bib33]). 30 µl extract was analysed using GC-MS (Waters GCT mass spectrometer, Agilent J and W DB-17MS column (30m × 0.25 mm x 0.25 µm)). The carrier gas was helium (flow rate: 0.8 ml/min). The column temperature gradient was as follows: 60°C initial, 20 °C/min increase to 100°C, 1 min hold, then 50 °C/min increase to 220°C. The injection volume was 1 µl and injector temperature was 220°C. The mass spectrometer operated in positive ion electron ionisation mode, the source temperature was 180°C and the range scanned was m/z 40--600 (scan time: 0.9 s). Mass spectral intensities for m/z values 58 and 59 were produced by combining the mass spectra in the acetone peak to create an averaged spectrum (Waters MassLynx). Serum ^2^H enrichment was calculated by comparison to a standard curve, and first order curve fitting (GraphPad Prism 8) used to calculate the rate constant (*k~p~*) and plateau (*p*~ss~) of deuterium enrichment ([Figure 1b](#fig1){ref-type="fig"}).

Protein extraction from whole tendon {#s4-4}
------------------------------------

Left Achilles tendons were thawed, and their surface scraped with a scalpel, followed by PBS washes, to remove the epitenon and any residual non-tendinous tissue. Tendons were finely chopped, flash frozen in liquid nitrogen and pulverised in a dismembrator (Sartorius, mikro-dismembrator U, 1800rpm, 2 mins.). Proteins were extracted using previously optimised methodologies ([@bib2]). Briefly, following deglycosylation in chondroitinase ABC, proteins were extracted in guanidine hydrocholoride (GuHCl) as described previously ([@bib23]). Protein content was determined using a Pierce protein assay according to the manufacturer's instructions. Samples were stored at −80°C prior to preparation for LC-MS/MS by centrifugal filtration. Filter units (Vivacon 500; 10 000 MWCO) were rinsed with 1%(v/v) formic acid and a balance volume of buffer (4M GuHCl/50 mM ammonium bicarbonate (ambic)) was added. A volume equivalent to 50 µg protein was added to each filter and the samples vortexed gently. Filters were centrifuged (15 min, 12500 rpm, 20°C), washed with GuHCl buffer and centrifuged again. Proteins were reduced by DTT incubation (100 µl of 8 mM in 4M GuHCl, 15 min, 56°C) and then centrifuged (10 min, 12500 rpm). DTT was removed by washing twice with buffer as described above. Proteins were alkylated with 100 μl 50 mM iodoacetamide in 4M GuHCl solution, vortexed and incubated in the dark (20 min., room temperature). Iodoacetamide was removed by washing twice with GuHCl buffer as described above. Buffer was exchanged to ambic by 3 washes with 50 mM ambic, centrifuging after each wash. 1 µg trypsin in 50 mM ambic (40 µl) was added and proteins digested overnight at 37°C with mixing. Flow through was collected after centrifugation and addition of 40 µl 50 mM ambic. The flow though was combined and acidified using trifluoroacetic acid (10%(v/v)), and diluted 20-fold in 0.1%(v/v) TFA/3%(v/v) acetonitrile for LC-MS/MS analysis.

Isolation and extraction of fascicular and interfascicular matrix proteins {#s4-5}
--------------------------------------------------------------------------

 Longitudinal cryosections (15 µm) from the right Achilles tendons (five time points, n = 2--3/time point) were adhered to membrane slides (PEN, Leica) and stored at −80°C. Sections were prepared for laser capture as described previously ([@bib59]) and approximately 1 mm^2^ of FM and IFM from each sample were collected into 50 µl molecular biology grade H~2~O (Leica LMD7000; [Figure 1a](#fig1){ref-type="fig"}). Samples were immediately frozen and stored at −80°C. Prior to digestion, samples were centrifuged immediately after removal from −80°C storage. Volume was adjusted to 80 µl by adding 50 mM ambic, and Rapigest SF (1%(v/v) in 25 mM ambic, Waters, UK) was added to a final volume of 0.1%(v/v). Samples were mixed (room temperature, 30 min) then incubated at 60°C (1 hr, 450 rpm). Samples were centrifuged (17200 g, 10 min), vortexed, then incubated at 80°C (10 min). Proteins were reduced by incubating with DTT (5 μL, 60 mM in 25 mM ambic, 10 min, 60°C) then alkylated by adding 5 μl 178 mM iodoacetamide in 25 mM ambic (30 min. incubation, room temperature, in dark). Trypsin (Promega Gold sequencing grade) was diluted in 25 mM ambic and added at an enzyme to protein ratio of 1:50 (based on estimated protein amount from tissue volume collected). Digests were incubated overnight at 37°C with an enzyme top-up after 3.5 hr. Rapigest was hydrolysed with TFA (0.5 μl, 37°C, 45 min.). Digests were centrifuged (17200 g, 30 min.), aspirated into low-bind tubes and de-salted on stage-tips as previously described ([@bib59]).

LC-MS/MS analyses {#s4-6}
-----------------

Data-dependent LC-MS/MS analyses were conducted on a QExactive quadrupole-Orbitrap mass spectrometer ([@bib63]; [@bib35]) coupled to a Dionex Ultimate 3000 RSLC nano-liquid chromatograph (Thermo Fisher, UK). Digest was loaded onto a trapping column (Acclaim PepMap 100 C18, 75 µm x 2 cm, 3 µm packing material, 100 Å) using a loading buffer of 0.1%(v/v) TFA, 2%(v/v) acetonitrile in water for 7 min (flow rate: 9 µl/min). The trapping column was set in-line with an analytical column (EASY-Spray PepMap RSLC C18, 75 µm x 50 cm, 2 µm packing material, 100 Å) and peptides eluted using a linear gradient of 96.2% A (0.1%(v/v) formic acid):3.8% B (0.1%(v/v) formic acid in water:acetonitrile \[80:20\](v/v)) to 50% A:50% B over 30 min (flow rate: 300 nl/min), followed by 1% A:99% B for 5 min and re-equilibration of the column to starting conditions. The column was maintained at 40°C, and the effluent introduced directly into the integrated nano-electrospray ionisation source operating in positive ion mode. The mass spectrometer was operated in DDA mode with survey scans between *m*/*z* 300--2000 acquired at a mass resolution of 70,000 (FWHM) at *m*/*z* 200. The maximum injection time was 250 ms, and the automatic gain control was set to 1e6. The 10 most intense precursor ions with charges states of between 2+ and 4+ were selected for MS/MS with an isolation window of 2 *m*/*z* units. The maximum injection time was 100 ms, and the automatic gain control was set to 1e5. Peptides were fragmented by higher-energy collisional dissociation using a normalised collision energy of 30%. Dynamic exclusion of *m*/*z* values to prevent repeated fragmentation of the same peptide was used (exclusion time: 20 s).

Peptide and protein identification {#s4-7}
----------------------------------

Proteins were identified from RAW data files, with trypsin specified as the protease, with one missed cleavage allowed and with fixed modifications of carbamidomethyl cysteine and variable modifications of oxidation of methionine and proline (Peaks Studio v8.5, Bioinformatics Solutions, Waterloo, Canada). Searches were performed against the UniProt *Rattus Norvegicus* database ([www.uniprot.org/proteomes](http://www.uniprot.org/proteomes)), with an FDR of 1%,≥2 unique peptides per protein and a confidence score \>20. Protein network analysis was performed using the Search Tool for Retrieval of Interacting Genes/Proteins (STRING), v11.0 ([@bib52]), and proteins were further classified using MatrisomeDB ([@bib18]) and the Protein ANalysis THrough Evolutionary Relationships (PANTHER) Classification System ([@bib34]). The proteomic data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository ([@bib37]) with the data set identifier PXD015928 and 10.6019/PXD015928.

Calculation of protein turnover rates {#s4-8}
-------------------------------------

 Peptides at each time point were identified using ProLuCID ([@bib64]) searching against a reverse-decoyed protein sequence database (UniProt *Rattus Norvigicus*, reviewed, accessed 23/04/2018). Fixed modifications of carbamidomethyl cysteine and ≤3 variable modifications of oxidation of methionine and proline were allowed. Tryptic, semi-tryptic, and non-tryptic peptides within a 15-ppm mass window surrounding the candidate precursor mass were searched. Protein identification was performed using DTASelect (v.2.1.4) ([@bib7]), with ≤1% global peptide FDR and ≥2 unique peptides per protein. Protein turnover rates and resulting half-lives were calculated using custom software (ProTurn v2.1.05; available at: <http://proturn.heartproteome.org>) as previously described and validated ([@bib29]; [@bib30]; [@bib31]; [@bib62]). Briefly, RAW files were converted into mzML format (ProteoWizard, v3.0.11781)([@bib1]) for input into ProTurn, along with DTAselect-filter text files for protein identification. ProTurn parameters were as follows: area-under-curve integration width: 60 p.p.m., extracted ion chromatograph smoothing: Savitzky-Golay filter ([@bib43]) over seven data points. Non-steady state curve fitting was used to account for the initial delay in uptake of ^2^H, using a first-order kinetic curve to approximate the equilibration of ^2^H~2~O in body water. Values of *k~p~* and *p*~ss~ were inputted from the resultant curve fitting of ^2^H enrichment in serum samples. To control against false positive identifications, only peptides that were explicitly identified in ≥4 data points were accepted for the calculation of protein turnover. The 'Allow Peptide Modification' option was selected to include any identified post-translationally modified peptides in kinetic curve-fitting, and peptide isotopomer time series were included if R^2^ ≥0.8 or standard error of estimate (S.E)≤0.05 ([@bib29]). Protein-level turnover rate is reported as the median and median absolute deviation of the turnover rate constants of each accepted unique constituent peptide, from which protein half-life can be calculated assuming a first order reaction ([@bib31]).

For some proteins of interest, particularly in the IFM, automated calculation of turnover rates was unsuccessful, due to unsuccessful automated identification of isotopomer peaks. In these cases, turnover rate constants were calculated manually, using isotopomer peak height to calculate the relative abundance of M~0~ as a function of time (Thermo Xcalibur v2.2), and fitting first order kinetic curves to estimate *k* (GraphPad Prism v8.0.2). As the labelling pattern of each peptide is dependent on the number of available labelling sites (*N*), unlabelled relative abundance of the 0^th^ isotopomer (*a*), as well as the plateau level of enrichment of deuterium (*p*~ss~); these values were used to calculate the plateau values of the 0^th^ isotopomer (*A~0~*) which occurs when the peptide is fully labelled. *N* was calculated from the literature ([@bib29]; [@bib8]). *a* was calculated from the peptide sequence and natural abundance of heavy isotopes of carbon, nitrogen, oxygen and sulphur ([@bib29]). *p*~ss~ was calculated from the serum enrichment as detailed above. The following equation was then used to calculate the plateau of *A~0~*:$$A_{0,PLATEA} = a(1 - p_{ss})^{N}$$

Previous work demonstrates this accurately predicts the plateau measured experimentally ([@bib29]), therefore, for curve fitting calculations the plateau was constrained to the calculated value for each peptide. To assess the degree of differences in curve fitting performed by automated and manual approaches, *k* values were calculated using both approaches for 10 peptides. Resulting *k* values differed by an average of 23%. This method does not allow for direct comparison between manual and automated calculations of *k*, due to differences in curve fitting method, but does allow differences in peptide *k* values between IFM and FM to be assessed, when both are calculated manually.

Statistical analysis {#s4-9}
--------------------

When ≥ 3 peptides were identified corresponding to a particular protein, statistical differences in turnover rate constants in tendon phases were assessed using paired t-tests, Wilcoxon matched pairs tests, or Mann-Whitney tests, with p\<0.05 (GraphPad Prism, v8.2). The statistical test chosen was dependent on whether data were normally distributed, which was assessed with Kolmogorov-Smirnov tests, and whether the same peptides were identified in tendon phases, which allowed for paired statistical tests.
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###### Source data for [Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}.

ProTurn output for whole tendon. hl tab contains protein half-life information organized by peptide sequence and hl-data tab contains isotopomer relative abundance at each time point
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The proteomic data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the data set identifier PXD015928 and 10.6019/PXD015928. Source files for 2H enrichment data, ProTurn output files and manually calculated turnover rates are provided with the manuscript.
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**Acceptance summary:**

This is an interesting study that uses mass spectrometry combined with deuterium isotope labeling (via initial injection and D2O water ad lib) to gain an unbiased look at the protein composition and turnover in the interfascicular and fascicular (IFM and FM, respectively) matrix of the rat Achilles tendon. The results support the hypothesis that the proteome of the IFM is more dynamic than the FM, and point out that these data in this model system have relevance to tendinous tissue remodeling and repair.
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Thank you for submitting your work entitled \"Heterogeneity of proteome dynamics between connective tissue phases of adult tendon\" for consideration by *eLife*. Your article has been evaluated by Clifford Rosen as the Senior Editor, a Reviewing Editor and one peer reviewer.

There are some issues that need to be addressed before acceptance, as outlined below:

Reviewer \#1:

This is an interesting study that uses mass spectrometry combined with deuterium isotope labeling (via initial injection and D2O water ad lib) to gain an unbiased look at the protein composition and turnover in the interfascicular and fascicular (IFM and FM, respectively) matrix of the rat Achilles tendon. The results support the hypothesis that the proteome of the IFM is more dynamic than the FM, and point out that these data in this model system have relevance to tendinous tissue remodeling and repair.

Overall, the results were convincing that there is a difference in IFM and FM composition and turnover. However, some concerns were noted regarding the validation of some aspects of this model system. Addressing these concerns would strengthen the paper overall.

First, there were no corroborating data for the mass spectrometric results. For example, western blotting for IFM and IF proteins would be useful not only to corroborate the MS data but additionally, to gauge the efficiency of the separation of IFM and FM tissue sections and their relative levels of enrichment for at least 1 or a few selected proteins. An alternative approach (given the low amounts of IFM material) could include immunofluorescence or immunohistochemical staining of tendon sections for representative proteins.

Second, regarding the equal representation of sex in the experiments, justification for using only female rats should be offered.

The Discussion should address whether turnover of protein post translational modifications (e.g., glycosylation) is an important feature of tendinous remodeling. Also, the Discussion would be enhanced by a concise discussion of any relevant knockout mouse phenotypes that support the importance of IFM- or FM-expressed proteins to tendinous or other tissue function.

Finally, if this was not included, provision for submission of these MS/proteomic data should be made to an appropriate public-accessible data base (e.g., PRIDE, PRoteomics IDEntifications database), consistent with Journal policies.

Reviewer \#2:

This paper investigates the proteome dynamics in tendon by comparing calculated protein turnover rates in the interfascicular matrix (IFM) vs. the fascicular matrix (FM).

This is a very interesting study illustrating the different protein turnover rates in different regions of the tendon, isolated by laser capture microdissection. The methods used are highly adequate and the data interpretation is sound. The main conclusions drawn are supported by the data presented and the study is well presented in the manuscript.

In the database search (subsection "Peptide and Protein Identification") -- it seems like you did not use oxidation of proline as a variable modification, please comment. The number of collagen peptides identified would be significantly increased by using that modification and I would highly recommend a new search using this modification to see how the collagen data is affected.
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> Reviewer \#1:
>
> \[...\] Overall, the results were convincing that there is a difference in IFM and FM composition and turnover. However, some concerns were noted regarding the validation of some aspects of this model system. Addressing these concerns would strengthen the paper overall.
>
> First, there were no corroborating data for the mass spectrometric results. For example, western blotting for IFM and IF proteins would be useful not only to corroborate the MS data but additionally, to gauge the efficiency of the separation of IFM and FM tissue sections and their relative levels of enrichment for at least 1 or a few selected proteins. An alternative approach (given the low amounts of IFM material) could include immunofluorescence or immunohistochemical staining of tendon sections for representative proteins.

Thank you for this useful suggestion. We were planning to immunolabel some tendon sections for key ECM proteins (collagen types 1 and 3, decorin, biglycan, fibromodulin) but unfortunately have not been able to do so due to lab closures as a result of COVID-19. However, distribution of these proteins within tendon is well described in the literature, and we have discussed our findings in light of these (Discussion, third and ninth paragraphs).

> Second, regarding the equal representation of sex in the experiments, justification for using only female rats should be offered.

Thank you for raising this point. We used female rats to maintain consistency with a related study, for which female rats were chosen to reduce the possibility of having to singly house animals after surgery due to animals fighting (which is common in males). We have added use of a single sex as a limitation of the study (Discussion, second paragraph).

> The Discussion should address whether turnover of protein post translational modifications (e.g., glycosylation) is an important feature of tendinous remodeling. Also, the Discussion would be enhanced by a concise discussion of any relevant knockout mouse phenotypes that support the importance of IFM- or FM-expressed proteins to tendinous or other tissue function.

Thank you for raising this point, which we had not considered. We have added a section to the Discussion considering the effect of PTMs on tendon remodelling (Discussion, fourth paragraph). We have also expanded on the discussion of relevant KO mice phenotypes (Discussion, ninth paragraph).

> Finally, if this was not included, provision for submission of these MS/proteomic data should be made to an appropriate public-accessible data base (e.g., PRIDE, PRoteomics IDEntifications database), consistent with Journal policies.

The data have been uploaded to the PRIDE repository, as described in the subsection "Peptide and Protein Identification".

> Reviewer \#2:
>
> \[...\] In the database search (subsection "Peptide and Protein Identification") -- it seems like you did not use oxidation of proline as a variable modification, please comment. The number of collagen peptides identified would be significantly increased by using that modification and I would highly recommend a new search using this modification to see how the collagen data is affected.

Thank you for this suggestion, we have now included oxidation of proline as a variable modification in the searches, which has resulted in a large increase number of collagen peptides identified in whole tendon, FM and IFM (Results). We have re-calculated protein half-life using this data, which has allowed us to calculate the turnover rates of a number of additional minor collagens (see Figure 6). It has also increased the number of collagen type I peptides identified, increasing the significance of our results (see Figure 7).
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